Advanced search
Publication Cover
Expert Opinion on Drug Safety Volume 15, 2016 - Issue 7
Submit an article Journal homepage
1,142
Views
2
CrossRef citations to date
0
Altmetric
Editorial

AML therapy in the elderly: a time for a change

Alessandro IsidoriHaematology and Haematopoietic Stem Cell Transplant Center, AORMN, Pesaro, ItalyCorrespondence[email protected]
,
Federica LoscoccoHaematology and Haematopoietic Stem Cell Transplant Center, AORMN, Pesaro, Italy
&
Giuseppe VisaniHaematology and Haematopoietic Stem Cell Transplant Center, AORMN, Pesaro, Italy
Pages 891-892 | Received 27 Feb 2016, Accepted 05 Apr 2016, Published online: 18 Apr 2016

References

  • Döhner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152.
  • Ferrara F, Schiffer CA. Acute myeloid leukaemia in adults. Lancet. 2013;381:484–495.
  • Isidori A, Salvestrini V, Ciciarello M, et al. The role of the immunosuppressive microenvironment in acute myeloid leukemia development and treatment. Expert Rev Hematol. 2014;7(6):807–818.
  • Isidori A, Venditti A, Maurillo L, et al. Alternative novel therapies for the treatment of elderly acute myeloid leukemia patients. Expert Rev Hematol. 2013;6(6):767–784.
  • Kantarjian HM, Ravandi F, O’Brien S. Intensive chemotherapy does not benefit most older patients (age 70 years or older) with acute myeloid leukemia. Blood. 2010;116:4422–4429.
  • Nazha A, Ravandi F. Acute myeloid leukemia in the elderly: do we know who should be treated and how? Leuk Lymph. 2014;55(5):979–987.
  • Sekeres MA, Steensma DP. Boulevard of broken dreams: drug approval for older adults with acute myeloid leukemia. J Clin Oncol. 2012;30(33):4061–4063.
  • Thomas X, Le Jeune C. The safety of treatment options for elderly people with acute myeloid leukemia. Expert Opin Drug Saf. 2016 Mar 17:1–11. [Epub ahead of print].
  • Visani G, Ferrara F, Di Raimondo F, et al. Low-dose lenalidomide plus cytarabine induce complete remission that can be predicted by genetic profiling in elderly acute myeloid leukemia patients. Leukemia. 2014 Apr;28(4):967–970.
  • Ferrara F, Barosi G, Venditti A, et al. Consensus-based definition of unfitness to intensive and non-intensive chemotherapy in acute myeloid leukemia: a project of SIE, SIES and GITMO group on a new tool for therapy decision making. Leukemia. 2013;27(5):997–999.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.